The quantitative structure-activity relationship (QSAR) market is expected to reach US$ 1,888.5 million by 2027 from US$ 1,388.1 million in 2019; it is estimated to grow at a CAGR of 4.0% from 2020 to 2027.
In 2019, the Royal Free London NHS Foundation Trust entered into a five-year partnership with DeepMind Technologies (Google), wherein the company is expected to assist the NHS in discovering therapies for the management of acute kidney injuries. The 100,000 Genomes Project of the UK is a global project that utilizes data and AI from NHS patients with rare diseases. The project also has Roche, Merck, and Biogen as partners. Thus, a rise in number of partnerships between pharmaceutical industries and AI companies, and government organizations has been witnessed on the global scale.
Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00018665/?utm_source=FreePlatform&utm_medium=10389
